Abstract:Mutations of the adenomatous polyposis coli tumor suppressor gene, or its downstream target β‐catenin, have been implicated in the initiation of most sporadic human colorectal epithelial neoplasms. These mutations, in turn, lead to aberrant nuclear accumulation of β‐catenin and subsequent activation of the β‐catenin/Tcf transcription factor complex. In vitro studies utilizing cultured human colon cancer cell lines have identified c‐myc, cyclin D1 and fra‐1 as target genes of β‐catenin/Tcf signaling. In our study, 12 cases of human colorectal adenocarcinomas were examined by Western immunoblotting analysis and immunohistochemical staining to specifically investigate whether the protein expression of these target genes was indeed altered in vivo by β‐catenin dysregulation. The results show that the protein level of β‐catenin was significantly increased in all 12 tumors (3.4 ± 1.0‐fold increase compared to the control normal mucosa by Western immunoblotting, p < 0.05), and this increase was associated with positive nuclear staining by immunohistochemistry in 10 cases. Increased levels of expression of cyclin D1 and Fra‐1 proteins were also demonstrated in every tumor (9.0 ± 2.7 and 3.3 ± 0.9‐fold increases compared to normal mucosa, respectively). Surprisingly, the protein level of c‐Myc was significantly decreased in all tumors examined by 49 ± 19% (p < 0.05), but the c‐myc mRNA level was increased in 8 of 12 tumors when compared to that in normal mucosa by RT‐PCR. Immunohistochemical staining performed on these carcinomas and additional 27 colorectal carcinomas further demonstrated that the protein expression level of c‐Myc and β‐catenin nuclear localization were not correlated. Moreover, 15 of 20 colorectal adenomas exhibited positive nuclear β‐catenin immunostaining, among which 11 also exhibited increased c‐Myc protein expression. These data thus support the notion that upregulation of cyclin D1 and Fra‐1 in human colorectal adenocarcinomas is driven by abnormally expressed β‐catenin. However, the regulation of c‐myc expression in colorectal tumors appears to be more complex. While dysregulated β‐catenin may cause a transcriptional upregulation of the c‐myc gene, the c‐Myc protein expression appears to be further regulated by a posttranscriptional mechanism(s) during the process of neoplastic progression. © 2002 Wiley‐Liss, Inc.

Beta- and Gamma-Catenin Mutations, but Not E-cadherin Inactivation, Underlie T-cell Factor/lymphoid Enhancer Factor Transcriptional Deregulation in Gastric and Pancreatic Cancer.

Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC

The APC tumor suppressor counteracts beta-catenin activation and H3K4 methylation at Wnt target genes

Β-Catenin/tcf4 Complex Induces the Epithelial-to-mesenchymal Transition (Emt)-Activator ZEB1 to Regulate Tumor Invasiveness.

Elevated Protein Expression of Cyclin D1 and Fra‐1 but Decreased Expression of C‐myc in Human Colorectal Adenocarcinomas Overexpressing Β‐catenin

Regulation of the phosphorylation and nuclear import and export of β-catenin by APC and its cancer-related truncated form.

Wnt-independent Beta-Catenin Transactivation in Tumor Development.

Aberrant Wnt/beta-catenin signaling in pancreatic adenocarcinoma.

537 Reg IV Induces β-Catenin Nuclear Translocation to Induce Cell Proliferation in Human Colon Adenocarcinomas

APC Mutations Disrupt Β-Catenin Destruction Complex Condensates Organized by Axin Phase Separation

Aberrant Wnt/β-Catenin Signaling in Pancreatic Adenocarcinoma

To β or not to β: Lack of correlation between APC mutation and β-catenin nuclear localization in colorectal cancer

Subcellular Localization of Mutated Β-Catenins with Different Incidences of Cis-Peptide Bonds at the Xaa246-P247 Site in HepG2 Cells.

β-Catenin signaling in hepatocellular cancer: Implications in inflammation, fibrosis, and proliferation

beta-Catenin regulates the expression of tenascin-C in human colorectal tumors

Genotype‐phenotype correlation of CTNNB1 mutations reveals different ß‐catenin activity associated with liver tumor progression

Reduced Membranous and Ectopic Cytoplasmic Expression of Β ‐catenin Correlate with Cyclin D1 Overexpression and Poor Prognosis in Pancreatic Cancer

Gut-enriched Krüppel-like factor regulates colonic cell growth through APC/beta-catenin pathway.

Mutations in components of the Wnt signaling pathway in gastric cancer.

Heterogeneous Expression and Association of Β‐catenin, P16 and C‐myc in Multistage Colorectal Tumorigenesis and Progression Detected by Tissue Microarray

TFCP2 Activates Beta-Catenin/tcf Signaling in the Progression of Pancreatic Cancer.